Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Radiation Oncology, Precision Immunology Institute
Fingerprint
Dive into the research topics where Robert Samstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An immunogenetic basis for lung cancer risk
Krishna, C., Tervi, A., Saffern, M., Wilson, E. A., Yoo, S. K., Mars, N., Roudko, V., Cho, B. A., Jones, S. E., Vaninov, N., Selvan, M. E., Gümüş, Z. H., FinnGen, Lenz, T. L., Merad, M., Boffetta, P., Martínez-Jiménez, F., Ollila, H. M., Samstein, R. M. & Chowell, D., 23 Feb 2024, In: Science. 383, 6685, p. 1-18 18 p., eadi3808.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial(Nature Medicine, 10.1038/s41591-023-02568-1)
Galsky, M. D., Daneshmand, S., Izadmehr, S., Gonzalez-Kozlova, E., Chan, K. G., Lewis, S., Achkar, B. E., Dorff, T. B., Cetnar, J. P., Neil, B. O., D’Souza, A., Mamtani, R., Kyriakopoulos, C., Jun, T., Gogerly-Moragoda, M., Brody, R., Xie, H., Nie, K., Kelly, G. & Horowitz, A. & 20 others, , Apr 2024, In: Nature Medicine. 30, 4, p. 1211 1 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery
IELCART Investigators & I-ELCAP, Mar 2024, In: Journal of Thoracic Oncology. 19, 3, p. 476-490 15 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Chest and thorax: Symptoms and toxicities
Bloom, J. R. & Samstein, R. M., 1 Jan 2023, Palliative Radiation Oncology. Elsevier, p. 359-366 8 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Galsky, M. D., Daneshmand, S., Izadmehr, S., Gonzalez-Kozlova, E., Chan, K. G., Lewis, S., Achkar, B. E., Dorff, T. B., Cetnar, J. P., Neil, B. O., D’Souza, A., Mamtani, R., Kyriakopoulos, C., Jun, T., Gogerly-Moragoda, M., Brody, R., Xie, H., Nie, K., Kelly, G. & Horwitz, A. & 19 others, , Nov 2023, In: Nature Medicine. 29, 11, p. 2825-2834 10 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations
Press/Media
-
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC
2/10/24
1 item of Media coverage
Press/Media
-
Findings from Icahn School of Medicine at Mount Sinai in the Area of Lung Cancer Described [Prospective Cohort Study To Compare Long-term Lung Cancer-specific and All-cause Survival of Clinical Early Stage (T1a-b; 20 Mm) Nsclc Treated By ...]
Samstein, R., Tannous, H., Henschke, C., Connery, C., Flores, R., Yankelevitz , D., Taioli, E., Rosenzweig, K. & Lee, P.
20/05/24
1 item of Media coverage
Press/Media
-
Study Reveals New Insights Into Immune System Role in Lung Cancer Risk
Saffern, M., Vaninov, N., Roudko, V., Merad, M., Samstein, R. & Chowell, D.
14/03/24
1 item of Media coverage
Press/Media
-
New insights into immune system role in lung cancer risk
Saffern, M., Vaninov, N., Merad, M., Samstein, R. & Chowell, D.
24/02/24
1 item of Media coverage
Press/Media
-
Study reveals new insights into immune system role in lung cancer risk
24/02/24
1 item of Media coverage
Press/Media